- Previous Close
296.50 - Open
295.12 - Bid 289.88 x --
- Ask 293.80 x --
- Day's Range
289.88 - 295.28 - 52 Week Range
272.75 - 350.31 - Volume
48,440 - Avg. Volume
130,393 - Market Cap (intraday)
18.967B - Beta (5Y Monthly) 0.46
- PE Ratio (TTM)
53.48 - EPS (TTM)
5.42 - Earnings Date Feb 14, 2025
- Forward Dividend & Yield 4.20 (1.45%)
- Ex-Dividend Date Sep 17, 2024
- 1y Target Est
294.95
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
www.cochlear.comRecent News: COH.AX
View MorePerformance Overview: COH.AX
Trailing total returns as of 12/31/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: COH.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: COH.AX
View MoreValuation Measures
Market Cap
18.97B
Enterprise Value
18.70B
Trailing P/E
53.38
Forward P/E
45.45
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.52
Price/Book (mrq)
10.31
Enterprise Value/Revenue
8.36
Enterprise Value/EBITDA
32.30
Financial Highlights
Profitability and Income Statement
Profit Margin
15.96%
Return on Assets (ttm)
11.99%
Return on Equity (ttm)
19.88%
Revenue (ttm)
2.24B
Net Income Avi to Common (ttm)
356.8M
Diluted EPS (ttm)
5.42
Balance Sheet and Cash Flow
Total Cash (mrq)
513.6M
Total Debt/Equity (mrq)
13.24%
Levered Free Cash Flow (ttm)
246.05M